PTC Therapeutics
PTCT
PTCT
114 hedge funds and large institutions have $615M invested in PTC Therapeutics in 2017 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 38 increasing their positions, 38 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
0% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 38
1% less funds holding
Funds holding: 115 → 114 (-1)
9.91% less ownership
Funds ownership: 91.23% → 81.32% (-9.9%)
Holders
114
Holding in Top 10
5
Calls
$19.1M
Puts
$9.92M
Top Buyers
| 1 | +$72.3M | |
| 2 | +$36.6M | |
| 3 | +$13.6M | |
| 4 |
Morgan Stanley
New York
|
+$9.19M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$7.91M |
Top Sellers
| 1 | -$22.9M | |
| 2 | -$13.7M | |
| 3 | -$9.65M | |
| 4 |
Millennium Management
New York
|
-$7.36M |
| 5 |
BB
BB Biotech
Schaffhausen,
Switzerland
|
-$6.72M |